Novartis
NVS
#58
Rank
S$276.79 B
Marketcap
$138.40
Share price
-0.17%
Change (1 day)
8.63%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Operating Margin for Novartis (NVS)

Operating Margin as of November 2024 (TTM): 25.49%

According to Novartis's latest financial reports and stock price the company's current Operating Margin is 25.49%. At the end of 2023 the company had an Operating Margin of 19.55%.

Operating Margin history for Novartis from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202319.55%18.4%
202216.51%-70.4%
202155.78%181.78%
202019.80%7.79%
201918.37%-39.93%
201830.58%45.8%
201720.97%32.62%
201615.81%-2.05%
201516.14%-29.45%
201422.88%11.61%
201320.50%-5.18%
201221.62%21.62%
201117.78%-21.67%
201022.70%3.17%
200922.00%-1.38%
200822.31%16.04%
200719.22%-15.58%
200622.77%-1.34%
200523.08%-1.79%
200423.50%2.17%
200323.00%-15.73%
200227.29%9.14%
200125.01%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
3.14%-87.68%๐Ÿ‡บ๐Ÿ‡ธ USA
1.80%-92.94%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-30.64%๐Ÿ‡บ๐Ÿ‡ธ USA
15.40%-39.58%๐Ÿ‡ซ๐Ÿ‡ท France
10.36%-59.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
-3.93%-115.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-14.50%-156.89%๐Ÿ‡บ๐Ÿ‡ธ USA
16.44%-35.50%๐Ÿ‡บ๐Ÿ‡ธ USA
15.05%-40.96%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.